Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
QNCX
2 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in QUINCE THERAPEUTICS INC
No. Balyasny Asset Management exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 27,753 shares worth $92,973. Balyasny Asset Management first reported QNCX in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$92,973
Total Shares Change
-27,753
Quarter-by-Quarter History